MKI67 and neoplasm: The cell proliferation marker (Ki67) staining was also significantly decreased in tumors treated with cinobufagin compared with that in vehicle-treated tumors (Figure 5C), suggesting that this compound strongly inhibits tumor cell proliferation in vivo.